Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Enzyme Inhib Med Chem ; 24(2): 499-505, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18608752

RESUMO

Reaction of 4,4-biphenyl-disulfonyl chloride with aromatic/heterocyclic sulfonamides also incorporating a free amino group, such as 4-aminobenzenesulfonamide, 4-aminoethyl-benzenesulfonamide, 6-chloro-4-aminobenzene-1,3-disulfonamide or 5-amino-1,3,4-thiadiazole-2-sulfonamide afforded bis-sulfonamides which have been tested as inhibitors of the zinc enzyme carbonic anhydrase (CA, EC 4..2.1.1). The compounds were rather modest inhibitors of isozymes CA I and XII, but were more efficient as inhibitors of the cytosolic CA II and transmembrane, tumor-associated CA IX (inhibition constants in the range of 21-129 nM gainst hCA II, and 23-79 nM against hCA IX, respectively). The new bis-sulfonamides also showed inhibition of growth of several tumor cell lines (ex vivo), with GI(50) values in the range of 0.74-10.0 microg/mL against the human colon cancer cell line HCT116, the human lung cancer cell line H460 and the human breast cancer cell line MCF-7.


Assuntos
Antineoplásicos/toxicidade , Inibidores da Anidrase Carbônica/toxicidade , Anidrases Carbônicas/metabolismo , Sulfonamidas/toxicidade , Antineoplásicos/química , Neoplasias da Mama/enzimologia , Neoplasias da Mama/metabolismo , Neoplasias do Colo/enzimologia , Neoplasias do Colo/metabolismo , Relação Dose-Resposta a Droga , Feminino , Células HCT116 , Humanos , Isoenzimas/antagonistas & inibidores , Isoenzimas/metabolismo , Neoplasias Pulmonares/enzimologia , Neoplasias Pulmonares/metabolismo
2.
Asian Pac J Cancer Prev ; 17(9): 4367-4375, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27797246

RESUMO

The objective of the present study was to evaluate the anticancer and radio-sensitizing efficacy of a Withania somnifera extract/Gadolinium III oxide nanocomposite (WSGNC) in mice. WSGNC was injected to solid Ehrlich carcinoma-bearing mice via i.p. (227 mg/kg body weight) 3 times/week during 3 weeks. Irradiation was performed by whole body fractionated exposure to 6Gy, applied in 3 doses of 2 Gy/week over 3 weeks. Biochemical analyses as well as DNA fragmentation were performed. Treatment of solid Ehrlich carcinoma bearing mice with WSGNC combined with γ-radiation led to a significant decrease in the tumor size and weight associated with a significant decrease in mitochondrial enzyme activities, GSH content and SOD activity as well as a significant increase in caspase-3 activity, MDA concentration and DNA fragmentation in cancer tissues. Combined treatment of WSGNC and low dose of γ-radiation showed great amelioration in lipid peroxidation and antioxidant status (GSH content and SOD activity) in liver tissues in animals bearing tumors. It is concluded that WSGNC can be considered as a radio-sensitizer and anticancer modulator, suggesting a possible role in reducing the radiation exposure dose during radiotherapy.


Assuntos
Carcinoma de Ehrlich/tratamento farmacológico , Nanocompostos/administração & dosagem , Extratos Vegetais/farmacologia , Radiossensibilizantes/farmacologia , Withania/química , Animais , Antioxidantes/metabolismo , Carcinoma de Ehrlich/metabolismo , Caspase 3/metabolismo , Linhagem Celular Tumoral , Fragmentação do DNA/efeitos dos fármacos , Feminino , Gadolínio/metabolismo , Raios gama , Glutationa/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Camundongos , Extratos Vegetais/química , Radiossensibilizantes/química , Superóxido Dismutase/metabolismo , Irradiação Corporal Total/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA